4:45 PM
 | 
Jun 22, 2010
 |  BC Extra  |  Politics & Policy

FDA finalizes lupus guidance

FDA issued final guidance on the development of products to treat systemic lupus erythematosus (SLE) and lupus nephritis caused by SLE. The documents...

Read the full 105 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >